These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8166557)

  • 1. Thromboxane A2 receptor-specific antagonism in hypothermic cardiopulmonary bypass.
    Mendeloff EN; Liang IY; Swain JA; Clark RE
    Ann Thorac Surg; 1994 Apr; 57(4):999-1006. PubMed ID: 8166557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep.
    Montalescot G; Lowenstein E; Ogletree ML; Greene EM; Robinson DR; Hartl K; Zapol WM
    Circulation; 1990 Nov; 82(5):1765-77. PubMed ID: 2146041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA; Heran CL; Ogletree ML
    Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane A2 receptor blockade improves contractile function following cardiopulmonary bypass in dogs and pigs.
    Kulatilake N; Gonzalez-Lavin L; Grover GJ
    J Surg Res; 1991 Oct; 51(4):336-40. PubMed ID: 1833590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of thromboxane receptor antagonist on hemodynamic responses after neutralization of heparin by protamine].
    Yoshioka M; Wakamatsu M; Kuro M; Okumura F
    Masui; 1991 Jun; 40(6):918-22. PubMed ID: 1875538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
    Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
    Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
    Morel DR; Costabella PM; Pittet JF
    Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonic acid metabolism after heparin reversal with protamine.
    Katircioğlu SF; Kücükaksu DS; Tasdemir O; Bayazit K
    Ann Thorac Surg; 1995 Feb; 59(2):550-1. PubMed ID: 7847996
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary microvascular responses to protamine and histamine. Effects of cardiopulmonary bypass.
    Friedman M; Johnson RG; Wang SY; Dai HB; Thurer RL; Weintraub RM; Sellke FW
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1092-9. PubMed ID: 7983878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
    Nuttall GA; Murray MJ; Bowie EJ
    Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of complement-induced pulmonary hypertension and improvement of right ventricular function by selective thromboxane receptor antagonism.
    Smith WJ; Murphy MP; Appleyard RF; Rizzo RJ; Aklog L; Laurence RG; Cohn LH
    J Thorac Cardiovasc Surg; 1994 Mar; 107(3):800-6. PubMed ID: 8127109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a thromboxane receptor antagonist (NT-126) and a thromboxane synthase inhibitor (OKY-O46) on protamine-induced circulatory changes in dogs.
    Mizutani T; Takahashi S; Kihara S; Toyooka H
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):687-92. PubMed ID: 11139110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The haemodynamic effects of the thromboxane A2 receptor antagonist GR32191B during cardiopulmonary bypass in the dog.
    Mathie RT; Fleming JS; Barrow SE; Arnold JV; Brannan JJ; Becket JM; Ritter JM; Taylor KM
    Perfusion; 1995 Nov; 10(6):403-13. PubMed ID: 8747897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
    Grover GJ; Schumacher WA
    J Pharmacol Exp Ther; 1989 Feb; 248(2):484-91. PubMed ID: 2521899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
    Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
    Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac-derived thromboxane A2. An initiating mediator of reperfusion injury?
    Byrne JG; Appleyard RF; Sun SC; Couper GS; Sloane JA; Laurence RG; Cohn LH
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):689-93. PubMed ID: 8469003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a thromboxane synthetase inhibitor on protamine-induced circulatory changes in sheep.
    Sugi K; Esato K
    Surgery; 1993 Sep; 114(3):586-90. PubMed ID: 8367815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.